SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-24-000572
Filing Date
2024-06-20
Accepted
2024-06-20 17:15:31
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLCORBIMED CAPITAL GP VIII LLCORBIMED GENESIS GP LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 ss3536341_sc13da.htm SC 13D/A 118757
2 JOINT FILING AGREEMENT ss3536341_ex9901.htm EX-99.1 7115
  Complete submission text file 0000947871-24-000572.txt   127752
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Subject) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91633 | Film No.: 241057454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)